FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults Read more
Catalent Expands Biologics Analytical Capabilities with New Laboratories at Center of Excellence in Kansas City, Missouri Read more
Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp DBC instrument Read more
PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer Read more
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership Read more